7 Results for "

p-STAT3 (Tyr-705)

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "p-STAT3 (Tyr-705)" in MCE Product Catalog:

Cat. No.: HY-153188
CAS No.: 2597343-08-1
Purity:  99.80%
Target:  

PROTACs Apoptosis IRAK

Research Areas:  

Cancer

JNJ-1013 is a potent and selective IRAK1 PROTAC degrader with an IC50s of 72, 443, 1071 nM for IRAK1, IRAK4, VHL FP respectively. JNJ-1013 induces apoptosis and increases the expression of cleavaged PARP. JNJ-1013 decreases the expression IRAK1, p-IKBα, pSTAT3(Tyr705) (Pink: ligand for target protein (HY-138834); black: linker (HY-Y1760); Blue: E3 ligase ligand (HY-112078)) .
loading...
    loading...
Cat. No.: HY-12352
CAS No.: 1617518-22-5
Target:  

STAT Apoptosis

Research Areas:  

Cancer

HJC0416 is a potent and orally active STAT3 inhibitor. HJC0416 shows antiprolifeative activity and induces Apoptosis. HJC0416 decreases the expression of p-STAT3 (Tyr-705), Cyclin D1 and increases the expression of cleaved caspase-3 protein. HJC0416 shows anti-tumor activity .
loading...
    loading...
Cat. No.: HY-170946
Target:  

STAT Bcl-2 Family

Research Areas:  

Cancer

WR-S-462 is a STAT3 inhibitor. WR-S-462 effectively suppresses STAT3 phosphorylation and biological functions in vitro. WR-S-462 inhibits MDA-MB-231 cells with an IC50 of 0.03 μM. WR-S-462 displays a strong binding affinity towards the STAT3 protein with a Kd of 58 nM. WR-S-462 inhibits the nuclear translocation of p-STAT3, selectively inhibits the expression of p-STAT3 Tyr705 and downstream target genes regulated by STAT3 in MDA-MB-231 cells such as Cyclin D1, Bcl-2, and Bcl-xl. WR-S-462 inhibits TNBC (triple-negative breast cancer) growth and metastasis .
loading...
    loading...
Cat. No.: HY-P86737
Synonyms: STAT3(phospho Y705); p-STAT3(phospho Y705); phospho-STAT3(pTyr705); STAT3(phospho-Tyr705); p-STAT3(Tyr705); phosphorylated STAT3(pTyr705); p-STAT3; Acute Phase Response Factor; APRF; DNA binding protein APRF; FLJ20882; MGC16063; Signal Transductor and Activator of Transcription 3; STAT 3; STAT3_HUMAN.

Host:  

Mouse

Application:  

IHC-P, IHC-F, IF-Tissue

Reactivity:  

Human, Rat

loading...
    loading...
Cat. No.: HY-184419
Target:  

STAT Apoptosis

Research Areas:  

Cancer

YZZ-24 is a highly potent and selective STAT3 inhibitor featuring a Ki of 0.26 μM. YZZ-24 directly binds to STAT3 (STAT3 SH2 domain) and effectively inhibits STAT3 phosphorylation at tyrosine 705 (p-STAT3 Tyr705) and STAT3 phosphorylation at serine 727 (p-STAT3 Ser727), thereby blocking downstream oncogenic signaling and inducing apoptosis, while having minimal impact on upstream kinases. YZZ-24 can be used in colorectal cancer research .
loading...
    loading...
Cat. No.: HY-P86737A
Synonyms: STAT3(phospho Y705); p-STAT3(phospho Y705); phospho-STAT3(pTyr705); STAT3(phospho-Tyr705); p-STAT3(Tyr705); phosphorylated STAT3(pTyr705); p-STAT3; Acute Phase Response Factor; APRF; DNA binding protein APRF; FLJ20882; MGC16063; Signal Transductor and Activator of Transcription 3; STAT 3; STAT3_HUMAN.

Host:  

Mouse

Application:  

IHC-P, IHC-F, IF-Tissue

Reactivity:  

Human, Rat

loading...
    loading...
Cat. No.: HY-N13352
CAS No.: 475-39-8
Bufothionine is an alkaloid. Bufothionine can be isolated from Cinobufacini. Bufothionine induces mitochondria-mediated Apoptosis. Bufothionine significantly reduces serum IL-6 concentration, suppresses p-Stat3 tyr705, p-Stat3 ser727 and Jak2 expressions. Bufothionine upregulates Atg5, Atg7 and LC3Ⅱ expressions. Bufothionine induces Autophagy. Bufothionine suppresses PIM3 expression. Bufothionine relieves symptoms of H22-tumor-bearing mice and exerts anti-inflammation activity. Bufothionine exerts anti-cancer activities against gastric cancer .
loading...
    loading...